These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode. Benedetti A, Lattanzi L, Pini S, Musetti L, Dell'Osso L, Cassano GB. J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507 [Abstract] [Full Text] [Related]
3. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I (Trial 001) Investigators. J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369 [Abstract] [Full Text] [Related]
4. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. Vieta E, Cruz N, García-Campayo J, de Arce R, Manuel Crespo J, Vallès V, Pérez-Blanco J, Roca E, Manuel Olivares J, Moríñigo A, Fernández-Villamor R, Comes M. Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292 [Abstract] [Full Text] [Related]
5. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies. Zhang ZJ, Kang WH, Li Q, Tan QR. J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995 [Abstract] [Full Text] [Related]
6. Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study. Zhang ZJ, Kang WH, Tan QR, Li Q, Gao CG, Zhang FG, Wang HH, Ma XC, Chen C, Wang W, Guo L, Zhang YH, Yang XB, Yang GD. J Psychiatr Res; 2007 Nov; 41(3-4):360-9. PubMed ID: 16081106 [Abstract] [Full Text] [Related]
7. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D. Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797 [Abstract] [Full Text] [Related]
9. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN. Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835 [Abstract] [Full Text] [Related]
12. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS, Konarski JZ, Jones M, Paulsson B. J Affect Disord; 2007 Jun; 100 Suppl 1():S5-14. PubMed ID: 17391773 [Abstract] [Full Text] [Related]
13. Oxcarbazepine for acute affective episodes in bipolar disorder. Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH. Cochrane Database Syst Rev; 2011 Dec 07; (12):CD004857. PubMed ID: 22161387 [Abstract] [Full Text] [Related]
16. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH, EMBOLDEN II (Trial D1447C00134) Investigators. J Clin Psychiatry; 2010 Feb 07; 71(2):163-74. PubMed ID: 20122366 [Abstract] [Full Text] [Related]
17. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. Weisler RH, Kalali AH, Ketter TA, SPD417 Study Group. J Clin Psychiatry; 2004 Apr 07; 65(4):478-84. PubMed ID: 15119909 [Abstract] [Full Text] [Related]